Sign in: Staff/Students
The PLT Board team
The University of Liverpool and Queen’s University Belfast are participating in a joint-venture spin-out company to take forward a new class of materials known as porous liquids, invented by researchers at both institutions.
The University and Queen’s University will be investing in `Porous Liquid Technologies Ltd’, a spin-out formed around jointly created Intellectual Property that is being developed for a broad range of technological applications.
Professor Andy Cooper from the University’s Department of Chemistry and Professor Stuart James, from Queen’s University’s School of Chemistry and Chemical Engineering, invented the first examples of porous liquids technologies in 2015 with their research published in the journal Nature, funded by the Engineering and Physical Sciences Research Council. They have since been carrying out further research to increase the yield and effectiveness of the porous liquids.
Porous liquids are a new class of liquid materials that contain microscopic cavities or pores, each the size of a single molecule. They contain up to 10,000 times the number of cavities that are found in conventional liquids, and up to around 20 per cent of the liquid is actually empty space – creating new substances with a far greater absorption capacity than the base solvents.
Porous liquids can absorb large amounts of gas and can be tuned to selectively absorb one gas over another. Their major benefit is, unlike solids, that they can be circulated, meaning that they can be applied in a host of processes.
Originally, the technology had been developed with applications in large scale industrial separations in mind but the product is already attracting interest in a number of other applications such as in medical diagnostics and household products.
`Porous Liquid Technologies Ltd’ will provide solution-focused consulting, research and development, and technology licensing. In addition to University of Liverpool investment, Emma Nolan, Head of IP Commercialisation at the University of Liverpool, will take a board position with the company.
The IP Commercialisation Team works with academics at the University of Liverpool to protect and commercialise their research, either via spin-out or licensing.
Professor Anthony Hollander, PVC for Research and Impact at the University of Liverpool, said: “The University is delighted to be co-venturing in the spin out company `Porous Liquid Technologies’. This is an exciting innovation and we think there are benefits to be gained from further Joint Ventures between Universities in the future.”
Professor Andy Cooper is also Academic Director of the University’s Materials Innovation Factory, an £81 million project dedicated to the research and development of advanced materials.
A collaboration between the University and Unilever, the Materials Innovation Factory brings together materials chemistry expertise with the latest computational and robotic equipment to accelerate research and reduce the time it takes to develop new products which have the potential to address a range of societal challenges.
You must be logged in to post a comment.
All recent news
Heseltine Institute report for LCR APPG leads calls for Westminster to deliver “clean, green and inclusive growth”
Using Liverpool’s e-scooters safely
Llama antibodies have “significant potential” as potent COVID-19 treatment
COVID-19 hospital mortality rates not reducing in patients with history of cancer, study finds
Follow us on social media
Liverpool is leading a new global network to bring together animal & human #coronavirus research communities.
Funded by @UKRI partners include @APHAgovuk @roslininstitute @Pirbright_Inst @Cambridge_Uni
#OneHealth #LivUniCovid @ThePandemicInst @livuniHLS https://bit.ly/3AEEqHr
Preventing the next global pandemics depends on the collective capacity of universities. For @Wonkhe this morning I’ve written about Liverpool, Covid-19 and @ThePandemicInst, and what next: https://wonkhe.com/blogs/if-pandemics-are-predictable-could-they-be-preventable/
Researchers from @livuniHLS have contributed to new research showing that llama antibodies have 'significant potential' as a #COVID19 treatment.
Published in @NatureComms today, the study was led by @RosFrankInst.
#LivUniCovid | @molvirol | @LivUni_IVES